25 results
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
23 Sep 22
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
4:53pm
and voluntary salary reductions for several members of management. These changes have resulted in a reduction by approximately 25% of the current workforce
424B5
INM
InMed Pharmaceuticals Inc
3 Jun 22
Prospectus supplement for primary offering
9:45pm
consumer protections, emphasize prevention and wellness, improve quality and system performance, expand the health workforce, and curb rising health care
424B3
grjv91sw63gc p0
25 Apr 22
Prospectus supplement
5:02pm
424B3
mryr0hk
7 Apr 22
Prospectus supplement
4:46pm
S-3
devyj
4 Feb 22
Shelf registration
4:36pm
10-K
52hvp1d c5zv
24 Sep 21
Annual report
7:31am
424B3
d7up2b
22 Jul 21
Prospectus supplement
10:27am
424B3
hetg6qu7p4kmb
16 Mar 21
Prospectus supplement
12:00am
10-Q
2vmdpmptewxq6ccl7
17 Dec 20
Quarterly report
12:00am
424B4
xf9kxjnzh
13 Nov 20
Prospectus supplement with pricing info
8:52pm